Tryptophan Depletion Modulates Tryptophanyl-tRNA Synthetase-Mediated High-Affinity Tryptophan Uptake into Human Cells.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
27 11 2020
Historique:
received: 22 09 2020
revised: 07 11 2020
accepted: 25 11 2020
entrez: 2 12 2020
pubmed: 3 12 2020
medline: 24 7 2021
Statut: epublish

Résumé

The novel high-affinity tryptophan (Trp)-selective transport system is present at elevated levels in human interferon-γ (IFN-γ)-treated and indoleamine 2,3-dioxygenase 1 (IDO1)-expressing cells. High-affinity Trp uptake into cells results in extracellular Trp depletion and immune suppression. We have previously shown that both IDO1 and tryptophanyl-tRNA synthetase (TrpRS), whose expression levels are increased by IFN-γ, have a crucial function in high-affinity Trp uptake into human cells. Here, we aimed to elucidate the relationship between TrpRS and IDO1 in high-affinity Trp uptake. We demonstrated that overexpression of IDO1 in HeLa cells drastically enhances high-affinity Trp uptake upon addition of purified TrpRS protein to uptake assay buffer. We also clarified that high-affinity Trp uptake by Trp-starved cells is significantly enhanced by the addition of TrpRS protein to the assay buffer. Moreover, we showed that high-affinity Trp uptake is also markedly elevated by the addition of TrpRS protein to the assay buffer of cells overexpressing another Trp-metabolizing enzyme, tryptophan 2,3-dioxygenase (TDO2). Taken together, we conclude that Trp deficiency is crucial for high-affinity Trp uptake mediated by extracellular TrpRS.

Identifiants

pubmed: 33261077
pii: genes11121423
doi: 10.3390/genes11121423
pmc: PMC7760169
pii:
doi:

Substances chimiques

Buffers 0
Culture Media 0
IDO1 protein, human 0
Indoleamine-Pyrrole 2,3,-Dioxygenase 0
Recombinant Proteins 0
Interferon-gamma 82115-62-6
Tryptophan 8DUH1N11BX
Tryptophan Oxygenase EC 1.13.11.11
Tryptophan-tRNA Ligase EC 6.1.1.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Oncotarget. 2015 Sep 8;6(26):21979-92
pubmed: 26110569
J Biol Chem. 2016 Aug 12;291(33):16927-35
pubmed: 27358398
Trends Mol Med. 2004 Jan;10(1):15-8
pubmed: 14720581
Annu Rev Biochem. 1987;56:125-58
pubmed: 3304131
Physiol Rev. 1990 Jan;70(1):43-77
pubmed: 2404290
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):173-7
pubmed: 11773626
Nat Microbiol. 2016 Oct 17;2:16191
pubmed: 27748732
Biochemistry. 2007 Oct 9;46(40):11291-8
pubmed: 17877375
J Biol Chem. 2003 Aug 8;278(32):29525-31
pubmed: 12766158
Nucleic Acids Res. 2004 Feb 02;32(2):719-27
pubmed: 14757836
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2497-502
pubmed: 22308364
Blood. 2004 Jun 15;103(12):4619-21
pubmed: 15001472
Arch Biochem Biophys. 2001 Aug 1;392(1):71-8
pubmed: 11469796
Immunol Rev. 2008 Apr;222:206-21
pubmed: 18364004
J Am Chem Soc. 2007 Dec 19;129(50):15690-701
pubmed: 18027945
Biochim Biophys Acta. 2015 Feb;1848(2):453-62
pubmed: 25450809
Nature. 2011 Oct 12;478(7368):192-4
pubmed: 21993754
Biochemistry. 2005 Jan 11;44(1):225-32
pubmed: 15628863
J Biol Chem. 2018 Jun 1;293(22):8428-8438
pubmed: 29666190
FASEB J. 1991 Aug;5(11):2516-22
pubmed: 1907934
J Immunol. 2000 Apr 1;164(7):3596-9
pubmed: 10725715
J Invest Dermatol. 1993 Jun;100(6):775-9
pubmed: 8496617
J Immunol. 2002 Apr 15;168(8):3771-6
pubmed: 11937528
Oncoimmunology. 2018 Sep 5;7(12):e1486353
pubmed: 30524887
Cytokine. 1995 Jan;7(1):70-7
pubmed: 7749068
Trends Biochem Sci. 2004 May;29(5):250-6
pubmed: 15130561
Nature. 2011 Oct 05;478(7368):197-203
pubmed: 21976023
Annu Rev Biochem. 1979;48:601-48
pubmed: 382994
Science. 2002 Sep 13;297(5588):1867-70
pubmed: 12228717
Trends Immunol. 2013 Mar;34(3):137-43
pubmed: 23103127
Nat Chem Biol. 2012 Apr 15;8(6):547-54
pubmed: 22504299
Electrophoresis. 1999 Apr-May;20(4-5):984-93
pubmed: 10344276
Sci Rep. 2016 Oct 20;6:35169
pubmed: 27762317
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11520-4
pubmed: 1763065
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11269-74
pubmed: 15277680
Cancer Res. 2016 Nov 1;76(21):6193-6204
pubmed: 27651314
Sci Rep. 2016 Apr 20;6:24750
pubmed: 27094087
Trends Endocrinol Metab. 2009 Nov;20(9):436-43
pubmed: 19800252
J Immunol. 2011 Aug 15;187(4):1617-25
pubmed: 21742973
Trends Biochem Sci. 1993 Jul;18(7):263-7
pubmed: 7692626
J Clin Invest. 2018 Nov 1;128(11):5163-5177
pubmed: 30153112
J Exp Med. 1999 May 3;189(9):1363-72
pubmed: 10224276
Nat Rev Immunol. 2004 Oct;4(10):762-74
pubmed: 15459668
Trends Pharmacol Sci. 2018 Mar;39(3):307-325
pubmed: 29254698
Nat Struct Mol Biol. 2010 Jan;17(1):57-61
pubmed: 20010843
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2611-6
pubmed: 16477023
J Biol Chem. 2008 Jan 25;283(4):2070-7
pubmed: 17999956
J Exp Med. 2002 Aug 19;196(4):447-57
pubmed: 12186837
Physiol Rev. 1998 Oct;78(4):969-1054
pubmed: 9790568
Biochem Soc Trans. 2008 Dec;36(Pt 6):1120-3
pubmed: 19021508
Science. 1998 Aug 21;281(5380):1191-3
pubmed: 9712583
Immunol Today. 1999 Oct;20(10):469-73
pubmed: 10500295
J Clin Invest. 2018 Nov 1;128(11):4767-4769
pubmed: 30320601
Eur J Immunol. 2009 Oct;39(10):2755-64
pubmed: 19637229
Proc Natl Acad Sci U S A. 1981 Jan;78(1):129-32
pubmed: 6165986
J Leukoc Biol. 2006 Dec;80(6):1320-7
pubmed: 16997853
J Biol Chem. 1991 Dec 25;266(36):24245-8
pubmed: 1761529
Nat Med. 2003 Oct;9(10):1269-74
pubmed: 14502282
Int J Cancer. 2002 Sep 10;101(2):151-5
pubmed: 12209992
Proteins. 2014 Nov;82(11):3210-6
pubmed: 25066423

Auteurs

Takumi Yokosawa (T)

Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

Aomi Sato (A)

Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan.

Keisuke Wakasugi (K)

Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH